The increase in individualised medication treatments according to one’s genetical composition will positively impact on healthcare systems. However there will be ethical issues arising from this.
Individualised medical treatments help to treat illness directly without any tiral and errors which may take time and waste resources. In the meantime, there will be minimum allergic reactions or adverse side effects since the medicine is patient-centered. This support the healthcare systems to spend resources effectively. In addition, recovery processes of patients will be easier and time efficent. For instance, for a cancer patient, if personalised treatments are provided according to their cell mutations, the medicine will work on the patient effectively and recover from the health issue in a short time period.
In the meantime, there are ethical concerns associated with this development. Genetic data gathered by the health industry is sensitive information. It will provide a descreptive analyisis of what are the possible illnessess that person will possible have in future according to their genetics. With this there are chances to missuse this data by insurance companies, employers and other institutes against people. Afterwards, knowing the negative impact of having personal information out in the systems, people could have mental disorders such as anxiety. Additionally, high cost personalised treatments create a gap between the social groups allowing only wealthy individuals have access to it. For example, there will be instnaces where a patient who has a chance to have a heart failure in their later years according to the genetical evaluation, will be redundant by the employer in late thirties.
In conclusion, individualised medical treatments will bring many postive impact to health care systems and revolutionise. In contrast, the ethical considerations aligned with this is numerous.